Wolverine Trading’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.8M Buy
6,262
+5,140
+458% +$2.09M 0.06% 1879
2025
Q2
$362K Sell
1,122
-1,316
-54% -$364K 0.01% 3269
2025
Q1
$655K Sell
2,438
-4,885
-67% -$1.26M 0.02% 2666
2024
Q4
$1.73M Buy
+7,323
New +$1.93M 0.04% 2092
2024
Q3
Hold
0
4760
2024
Q2
Hold
0
4442
2024
Q1
Sell
-2,946
Closed -$491K 4440
2023
Q4
$564K Buy
+2,946
New +$502K ﹤0.01% 2830
2023
Q3
Hold
0
4464
2023
Q2
Hold
0
4219
2023
Q1
Sell
-1,323
Closed -$278K 4181
2022
Q4
$314K Buy
+1,323
New +$282K 0.01% 2720
2022
Q3
Sell
-2,997
Closed -$572K 4545
2022
Q2
$436K Buy
2,997
+1,425
+91% +$202K 0.01% 2676
2022
Q1
$260K Sell
1,572
-2,054
-57% -$313K 0.01% 4085
2021
Q4
$620K Buy
3,626
+1,482
+69% +$275K 0.01% 3192
2021
Q3
$380K Sell
2,144
-4,622
-68% -$867K 0.01% 4351
2021
Q2
$1.12M Buy
6,766
+2,394
+55% +$351K 0.03% 2631
2021
Q1
$591K Buy
4,372
+962
+28% +$145K 0.01% 3477
2020
Q4
$447K Buy
+3,410
New +$455K 0.01% 3294
2020
Q3
Hold
0
4475
2020
Q2
Hold
0
4532
2020
Q1
Sell
-5,440
Closed -$628K 4569
2019
Q4
$624K Buy
+5,440
New +$542K 0.01% 2872
2019
Q3
Sell
-7,356
Closed -$582K 4251
2019
Q2
$534K Buy
+7,356
New +$564K 0.02% 2648
2019
Q1
Sell
-13,618
Closed -$1.14M 4472
2018
Q4
$959K Sell
13,618
-12,860
-49% -$989K 0.03% 1996
2018
Q3
$2.32M Buy
+26,478
New +$2.66M 0.06% 1540
2018
Q2
Hold
0
5067
2018
Q1
Sell
-10,288
Closed -$1.33M 5084
2017
Q4
$1.31M Buy
+10,288
New +$1.29M 0.03% 1930
2017
Q1
Sell
-9,069
Closed -$340K 4183
2016
Q4
$340K Buy
+9,069
New +$380K 0.02% 3109

Other funds holding ALNY